Stockscreener 앱 받기
34.36
5.85%
1.90
시간 외 거래:
34.56
0.20
+0.58%
전일 마감가:
$32.46
열려 있는:
$32.97
하루 거래량:
339.90K
Relative Volume:
0.93
시가총액:
$2.38B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+4.76%
1개월 성능:
+12.69%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$32.80
$34.62
1주일 범위
$31.94
$35.28
52주 변동 폭
$18.84
$38.54
Alamar Biosciences Inc Stock (ALMR) Company Profile
명칭
Alamar Biosciences Inc
전화
510-626-9888
주소
47071 BAYSIDE PARKWAY, FREMONT
Compare ALMR vs ABT, MDT, SYK, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALMR
Alamar Biosciences Inc
|
34.36 | 2.28B | 0 | 0 | 0 | 0.00 |
ABT
Abbott Laboratories
|
97.50 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Alamar Biosciences Inc 주식(ALMR)의 최신 뉴스
Alamar Biosciences, Inc. (ALMR) stock price, news, quote and history - Yahoo Finance Singapore
Alamar Biosciences, Inc. (ALMR) Stock Price, News, Quote & History - Yahoo! Finance Canada
Among 197 Alzheimer’s patients, 34 of 130 blood markers changed as they received more infusions. - Stock Titan
Alamar Biosciences Study in The Lancet Neurology Finds Distinct Biomarker Responses to Lecanemab in Early Alzheimer’s Disease - Quiver Quantitative
Lancet Neurology Study Using Alamar Biosciences’ Technology - GlobeNewswire
Alamar Biosciences stock rating reiterated at Buy by TD Cowen - Investing.com South Africa
Alamar Biosciences, Inc.(NasdaqGS: ALMR) added to S&P Global BMI Index - marketscreener.com
Alamar Biosciences Shares Soar 15.90% Near 52-Week High Amid Growing Proteomics Analyst and Investor Buzz - International Business Times Australia
Why is Alamar Biosciences stock surging today? By Investing.com - Investing.com South Africa
Alamar Biosciences Soars After High-Profile Conference Buzz - TipRanks
Alamar Biosciences Tumbles As Post‑IPO Hype Fades - TipRanks
Alamar Biosciences, Inc. Common Stock (NASDAQ: ALMR) Stock Price, News & Analysis - Kalkine
Ragusa Robert P. Acquires 5,686 Shares and 25,599 Derivative Securities of Alamar Biosciences - Kalkine Media
Alamar Biosciences (ALMR) director has no reported share holdings - Stock Titan
People in the News at Pillar Biosciences, Devyser, Alamar Biosciences - genomeweb.com
Alamar Biosciences Slides After Conference Hype Fades - TipRanks
Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference - The Manila Times
Alamar Biosciences, Inc. Announces Appointment of Robert Ragusa as Director and Member of Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee, Effective September 1, 2026 - marketscreener.com
Alamar Biosciences appoints Robert Ragusa to Board and three committees - TradingView
Alamar Biosciences expands proteomics partnership by 86,000 samples - Investing.com Nigeria
Alamar Biosciences (ALMR) Q2 2026 Earnings Call Transcript - The Globe and Mail
Alamar Biosciences: Promising But Expensive Proteomics Growth - Seeking Alpha
Alamar Stock: The Content Flywheel Is More Valuable Than The Instrument (ALMR) - Seeking Alpha
Alamar Biosciences (ALMR) Stock Price Jumps As Margin Gains Meet Loss Pressure - Sahm
Alamar Biosciences (ALMR): Yuling Luo discloses 6.4% beneficial ownership stake - Stock Titan
Alamar Biosciences, Inc. (ALMR) Q2 2026 Earnings ReportResults, Call & Slides - TipRanks
Analysts Offer Insights on NA Companies: Alamar Biosciences, Inc. (ALMR), NIQ Global Intelligence PLC (NIQ) and Amentum Holdings, Inc. (AMTM) - The Globe and Mail
Alamar Biosciences Q2 Results: Revenue Rises 82% To $29.4 Million - scanx.trade
Alamar Biosciences Shares (ALMR) Surge 31% as Consumables Drive Gross Margin Up - TechStock²
Alamar Biosciences (ALMR): Qiming funds report over 10% ownership stake - Stock Titan
Alamar Biosciences launches NULISAseq Immune 340 Panel for profiling - scanx.trade
Stifel raises Alamar Biosciences stock price target on earnings beat By Investing.com - Investing.com Canada
Alamar Biosciences Reports Q2 2026 Financial Results in Form 10-Q Filing - Kalkine Media
ALAMAR BIOSCIENCES INC : STIFEL RAISES TARGET PRICE TO $32 FROM $28 - Bitget
Alamar Biosciences Q2 2026 Earnings Call Transcript - MarketBeat
Alamar Biosciences, Inc. Stock 12‑Month Price Target Raised to $33.4, Implies 19% Upside - TradingView
Alamar Biosciences, Inc. 2Q 2026: Revenue $29.4M, EPS $(0.22) — 10-Q Summary - TradingView
Alamar Biosciences Inc (ALMR) (Q2 2026) Earnings Call Highlights: Revenue Surges 82% on 147% ... - Yahoo Finance Singapore
Alamar Biosciences (ALMR) Stock Trades At A Premium To Its Sales - Yahoo Finance
Alamar Biosciences to report Q2 2026 results on August 10, 2026 - scanx.trade
Form 8K Alamar Biosciences For: 10 August By Investing.com - Investing.com Nigeria
Alamar Biosciences Q2 Earnings Call Highlights - MarketBeat
Alamar Biosciences Q2 revenue surges 82%, led by consumable demand - scanx.trade
Alamar Biosciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings call transcript: Alamar Biosciences posts strong Q2 2026 revenue growth - Investing.com
Alamar Biosciences, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:ALMR) 2026-08-10 - Seeking Alpha
ALAMAR BIOSCIENCES ($ALMR) Releases Q2 2026 Earnings - quiverquant.com
Alamar Biosciences Inc (ALMR) 재무 분석
Alamar Biosciences Inc (ALMR)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Alamar Biosciences Inc 주식 (ALMR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Naclerio Nicholas | Director |
Apr 20 '26 |
Buy |
17.00 |
235,294 |
3,999,998 |
507,076 |
0.26%
0.38%
자본화:
|
볼륨(24시간):